Roberto Contreras
Overview
Explore the profile of Roberto Contreras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Contreras R, van den Brink L, Burgos B, Gonzalez M, Gacitua S
Plants (Basel)
. 2020 Jun;
9(6).
PMID: 32545703
The hybridization of , a critically endangered endemic species, and the identification of its paternal species has not been genetically studied before. In this study we aimed to genetically confirm...
12.
Contreras R, Figueiras A, Gallego F, Benito C
Funct Plant Biol
. 2020 Jun;
41(12):1270-1283.
PMID: 32481076
Aluminium (Al) toxicity is the main abiotic stress limiting plant productivity in acidic soils. Studies on Al tolerance have been conducted in Poaceae but their genomes are very complex. Fifty-nine...
13.
Sanchez-Elordi E, Contreras R, de Armas R, Benito M, Alarcon B, de Oliveira E, et al.
J Plant Physiol
. 2018 May;
226:103-113.
PMID: 29753910
Proteomic profiling of the stalk of a smut resistant and a susceptible sugarcane cultivars revealed the presence of dirigent and dirigent-like proteins in abundance in the pool of high molecular...
14.
Contreras R, Figueiras A, Gallego F, Benavente E, Manzaneda A, Benito C
AoB Plants
. 2018 Jan;
9(6):plx060.
PMID: 29302302
Aluminium (Al) toxicity is the main abiotic stress limiting plant productivity in acidic soils that are widely distributed among arable lands. Plant species differ in the level of Al resistance...
15.
Castellon Y, Bazargan-Hejazi S, Masatsugu M, Contreras R
Am J Manag Care
. 2014 Apr;
20(2):146-50.
PMID: 24738532
Objectives: Patient assistance programs and the 340B Drug Pricing Program promise to improve the financial stability, better serve vulnerable patients, and decrease the burden of cost for uninsured patients. Our...